Goki Ishikawa
Präsident bei Fujirebio Holdings, Inc.
Profil
Goki Ishikawa is currently the President & Representative Director at Fujirebio Holdings, Inc. He previously held the position of President & Representative Director at Fujirebio, Inc. He completed his undergraduate degree at the University of Tokyo in 1999.
Aktive Positionen von Goki Ishikawa
| Unternehmen | Position | Beginn |
|---|---|---|
Fujirebio Holdings, Inc.
 Fujirebio Holdings, Inc. BiotechnologyHealth Technology Founded in 2017, Fujirebio Holdings, Inc. is a Japanese company that develops diagnostic products for neurodegenerative diseases. Part of H.U. Group Holdings, Inc., the company is based in Tokyo, Japan. | Präsident | 01.06.2020 |
Ehemalige bekannte Positionen von Goki Ishikawa
| Unternehmen | Position | Ende |
|---|---|---|
Fujirebio, Inc.
 Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | Präsident | - |
Ausbildung von Goki Ishikawa
| University of Tokyo | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Fujirebio, Inc.
Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | Health Technology |
Fujirebio Holdings, Inc.
Fujirebio Holdings, Inc. BiotechnologyHealth Technology Founded in 2017, Fujirebio Holdings, Inc. is a Japanese company that develops diagnostic products for neurodegenerative diseases. Part of H.U. Group Holdings, Inc., the company is based in Tokyo, Japan. | Health Technology |
